Completed

Pilot Study: The Effects of Whole Grapes on Markers of Health

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Grape in the form of freeze-dried whole grape powder

+ Grape powder placebo

Other
Who is being recruted

Body Weight+8

+ Nutrition Disorders

+ Nutritional and Metabolic Diseases

From 18 to 70 Years
+9 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Placebo-Controlled
Interventional
Study Start: August 2012
See protocol details

Summary

Principal SponsorUniversity of California, Davis
Last updated: May 30, 2017
Sourced from a government-validated database.Claim as a partner

Study start date: August 1, 2012

Actual date on which the first participant was enrolled.

The specific aims are to: Assess the effect of WGP compared to placebo on biomarkers of oxidative stress and inflammation in obese subjects over 4 week intervention periods in a randomized, cross-over, double-blind study. Determine the effects of WGP compared to placebo on lipid and apolipoprotein parameters, and on biomarkers endothelial dysfunction, in obese subjects. Investigate and characterize the effects of WGP compared to placebo on mononuclear cells (MNC) from obese subjects in response to the oxidative challenge of a high fat, high carbohydrate (HFHC) meal by examining monocyte indices such as oxidant stress-related transcription factors and downstream gene targets. Health promotion and prevention of chronic diseases in the face of a continuing obesity epidemic is the most pressing public health issue today. Epidemiologic evidence supports a protective effect of plant food-rich dietary patterns, and an inverse relationship of fruit and vegetable consumption with chronic conditions like cardiovascular disease (CVD). However, the underlying causal mechanisms are not well understood. Prospective human studies examining consumption of polyphenol-rich whole grapes or their components have found benefits on markers of oxidative stress and blood lipids as have other food examples such as blackcurrant juice and strawberries. Putative mechanisms underlying the positive actions of polyphenol-rich grapes have been well described in recent reviews. A number of in-vitro cell culture and in-vivo animal studies with WGP and extracts support these mechanisms. However, relatively fewer human studies have been conducted examining biomarkers and potential mechanisms for attenuation of chronic inflammatory responses and meal-induced postprandial oxidative stress and inflammation in obese humans. Obesity is a metabolic state recognized as being pro-inflammatory, leading to dysregulation of endothelial function, glucose and lipoprotein metabolism and cardiovascular risk. Consumption of high fat diets can further impair vascular reactivity in the postprandial period. Circulating MNC provide a representation of the overall inflammatory status of the body, which is accessible and can be used to examine mechanistic processes in response to chronic and meal-induced oxidative stress. Recent literature reports have described the effect of polyphenol-rich food consumption and Mediterranean diet patterns to reduce NF-κB activation as well as changes in downstream inflammatory gene expression in peripheral blood MNC's. Therefore, the proposed study will exploit this approach to examine short-term responses to a meal challenge as well as longer-term responses to daily consumption of whole grapes as assessed by plasma and mononuclear cell indices. This research will shed light on oxidant stress-related transcription factors and downstream gene targets involved in the anti-inflammatory effects of grape consumption in obese individuals who are at increased risk of chronic diseases. Additional scientific data is needed to understand the links between diet and health and to develop effective dietary strategies to improve health outcomes, particularly in obesity. The use of polyphenol-rich whole grape powder to attenuate inflammatory mediators and biomarkers in blood and mononuclear cells of obese humans represents a targeted intervention approach in an at-risk population. The goal for the study is to examine the link between the beneficial effects of grapes as a food and health in a significant public health chronic disease. The outcomes of the study design will provide preliminary data which bridges well-controlled human translational research and fundamental research by examining cellular responses to grape consumption in a human clinical trial. The approach will generate new and unique data to extend scientific knowledge and allow for the development of a mechanistic component to a human feeding intervention.

NCT01674231
Principal SponsorUniversity of California, Davis
Last updated: May 30, 2017
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

20 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 70 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Body WeightNutrition DisordersNutritional and Metabolic DiseasesPathologic ProcessesSigns and SymptomsPathological Conditions, Signs and SymptomsOvernutritionOverweightCardiovascular DiseasesInflammationObesity

Criteria

2 inclusion criteria required to participate
BMI > 30

Men and women 18 years of age or older in good health

7 exclusion criteria prevent from participating
Allergy to grapes

Chronic disease, such as diabetes, cancer, and renal, liver or thyroid dysfunction

History of cardiovascular events

History of gastrointestinal disease

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

50% chance of being blinded to the placebo group

Treatment Groups

Group I

Active Comparator
Grapes in the form of a Freeze-dried Whole Grape Powder. 60g freeze-dried whole grape powder with 296mg polyphenols per day for 4 weeks.

Group II

Placebo
Grape Powder Placebo. 60g control food (matched for calories, low in polyphenols, and indistinguishable from active intervention) per day for 4 weeks.

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Ragle Human Nutrition Center

Davis, United StatesOpen Ragle Human Nutrition Center in Google Maps
CompletedOne Study Center